NCT01911936View on ClinicalTrials.gov

A Phase I Study of LJM716 in Japanese Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Neoplasms
Interventions
DRUG

LM716

Trial Locations (2)

135-8550

Novartis Investigative Site, Koto

811-1395

Novartis Investigative Site, Fukuoka

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT01911936 - A Phase I Study of LJM716 in Japanese Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter